Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 92.04B |
| Revenue (ttm) | 26.12B |
| Net Income (ttm) | 3.58B |
| Shares Out | n/a |
| EPS (ttm) | 2.77 |
| PE Ratio | 25.70 |
| Forward PE | 16.44 |
| Dividend | 2.11 (2.18%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 28,752 |
| Average Volume | 5,394 |
| Open | 96.20 |
| Previous Close | 96.42 |
| Day's Range | 95.66 - 96.85 |
| 52-Week Range | 79.73 - 106.66 |
| Beta | 0.73 |
| RSI | 42.31 |
| Earnings Date | Feb 17, 2026 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic Partners With Precision Neuroscience to Develop Brain Surgery Imaging System
Medtronic Partners With Precision Neuroscience to Develop Brain Surgery Imaging System
Medtronic CEO Geoff Martha goes one-on-one with Jim Cramer
Medtronic Chairman and CEO Geoff Martha joins 'Mad Money' host Jim Cramer at the JPMorgan Health Care Conference to talk its recent growth and opportunities ahead.
Medtronic PLC at JPMorgan Healthcare Conference Transcript
Medtronic PLC at JPMorgan Healthcare Conference Transcript
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic plc (MDT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 1:30 PM ESTCompany ParticipantsGeoffrey Martha - Chairman of the Board...
Medtronic (MDT) Partners with Precision Neuroscience for Advanced Surgical Tech
Medtronic (MDT) Partners with Precision Neuroscience for Advanced Surgical Tech
Medtronic partnering with Precision Neuroscience on brain-computer interface
Medtronic has 'significant firepower' for multiple acquisitions, executives say
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off...
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2026-01-12. The following slide deck was published by Medtronic plc in conjunction with this event.
Medtronic Receives FDA Clearance For MiniMed Go Smart MDI Diabetes App
(RTTNews) - Medtronic (MDT), a medical device company, on Monday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MiniMed Go app. This clearance allows t...
Medtronic (MDT) Gains FDA Clearance for MiniMed Go App
Medtronic (MDT) Gains FDA Clearance for MiniMed Go App
Medtronic gains FDA clearance for MiniMed Go insulin dosing system app
FDA clears Medtronic’s MiniMed Go app for smart MDI, integrating InPen + Abbott sensor for real-time glucose, dose guidance and alerts. Read more now.
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily inject...
MDT: Bernstein Raises Price Target for Medtronic | MDT Stock News
MDT: Bernstein Raises Price Target for Medtronic | MDT Stock News
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens in 2026, though, Vertex and Medtronic have attractive prospects.
Barclays Raises Price Target for Medtronic (MDT) to $116 | MDT Stock News
Barclays Raises Price Target for Medtronic (MDT) to $116 | MDT Stock News
Why Is Medtronic Stock Trading Higher After Analyst Upgrade
William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers that could lift earnings and investor returns over the next few ... Full s...
Why Is Medtronic Stock Trading Higher After Analyst Upgrade
On Tuesday, William Blair upgraded Medtronic Plc (NYSE: MDT), citing several new and ramping launches.
Medtronic (MDT) Upgraded to Outperform by William Blair | MDT Stock News
Medtronic (MDT) Upgraded to Outperform by William Blair | MDT Stock News
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conferen...
2 Top Dividend Stocks to Buy for 2026
Visa has a resilient business, a solid competitive edge, and attractive avenues for growth. Medtronic is performing well, and new product launches are providing a potentially long-lasting tailwind.
Best Dividend Aristocrats For January 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%...
MDT a Top 25 Dividend Giant With $19.23B Held By ETFs
Medtronic PLC (Symbol: MDT) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $19.23B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a...
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device maker that's nearing Dividend King status.
Medtronic: A Strong Contender in the Medical Device Arena
Could Medtronic be the next big opportunity in the medical device sector? Join us as we break down its strengths, challenges, and future potential in this insightful episode.